6-(4-bromo-1-oxoisoindolin-2-yl)hexanoic acid | 1255951-75-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-(4-bromo-1-oxoisoindolin-2-yl)hexanoic acid
• 英文别名: 6-(7-bromo-3-oxo-1H-isoindol-2-yl)hexanoic acid
• CAS: 1255951-75-7
• 化学式: C₁₄H₁₆BrNO₃
• 分子量: 326.19
• InChiKey: LPZLDMDIMAIPIG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS<br/>[FR] DÉRIVÉS DE LA THIÉNO [2, 3-B] PYRIDINE EN TANT QU'INHIBITEURS DE RÉPLICATION VIRALE
  申请人：UNIV LEUVEN KATH

  公开号：WO2010130842A1

  公开（公告）日：2010-11-18

  The present invention relates to a series of compounds of formula (A) having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

  本发明涉及一系列具有抗病毒活性的化合物(A)的公式，更具体地说是具有抑制HIV（人类免疫缺陷病毒）复制的特性。该发明还涉及制备这类化合物的方法，以及在这类合成的一个或多个步骤中有用的新中间体。该发明还涉及包含有效量这类化合物作为活性成分的药物组合物。本发明进一步涉及将这类化合物用作药物或用于制造用于治疗患有病毒感染的动物，尤其是HIV感染的药物。本发明还涉及通过给予这类化合物的治疗量，可选地与一个或多个具有抗病毒活性的其他药物结合，来治疗动物的病毒感染的方法。
• ISOINDOLINONE DERIVATIVES, PREPARATION METHOD THEREOF AND A PHARMACEUTICAL COMPOSITION COMPRISING SAME
  申请人：Heo Jung Nyoung

  公开号：US20120065396A1

  公开（公告）日：2012-03-15

  The present invention relates to an amide compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition comprising the same. The inventive amide compound facilitates bone formation and inhibits bone loss, and is therefore useful for preventing and treating bone disorders such as osteoporosis, osteodystrophy, bone fracture, periodontal disease, Paget's disease, bone metastasis, and rheumatoid arthritis.

  本发明涉及一种酰胺化合物或其药学上可接受的盐，其制备方法以及包含它的制药组合物。本发明的酰胺化合物促进骨形成并抑制骨丢失，因此可用于预防和治疗骨疾病，如骨质疏松症、骨发育不良、骨折、牙周疾病、Paget病、骨转移和类风湿性关节炎。
• AMIDE COMPOUND, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  申请人：Korea Research Institute Of Chemical Technology

  公开号：EP2429987A2

  公开（公告）日：2012-03-21
• THIENO [2, 3-B]PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS
  申请人：Katholieke Universiteit Leuven

  公开号：EP2430029A1

  公开（公告）日：2012-03-21
• US8716326B2
  申请人：——

  公开号：US8716326B2

  公开（公告）日：2014-05-06